JILL NAKAYAMA: Open Payments
NPI 1831829332 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,611 in 63 payments from 14 companies in 2025. Trend: 2023 $438 · 2024 $782 · 2025 $1,611
Food & beverage: $1,611
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $612 |
| Novo Nordisk Inc | 7 | $234 |
| Vanda Pharmaceuticals Inc. | 2 | $140 |
| Lilly USA, LLC | 5 | $106 |
| Exact Sciences Corporation | 5 | $104 |
| PFIZER INC. | 5 | $103 |
| Gilead Sciences, Inc. | 3 | $61 |
| ViiV Healthcare Company | 2 | $54 |
| Exeltis, USA Inc. | 3 | $50 |
| GlaxoSmithKline, LLC. | 2 | $46 |
Products named: QULIPTA, VRAYLAR, Wegovy, FANAPT, NURTEC ODT, MOUNJARO, Cologuard Collection Kit, APRETUDE.
Industry payments across CO — which companies pay providers there.
